141 related articles for article (PubMed ID: 1847982)
21. Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells.
Sawyer ST; Krantz SB; Luna J
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3690-4. PubMed ID: 3035548
[TBL] [Abstract][Full Text] [Related]
22. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.
Mitjavila MT; Le Couedic JP; Casadevall N; Navarro S; Villeval JL; Dubart A; Vainchenker W
J Clin Invest; 1991 Sep; 88(3):789-97. PubMed ID: 1653276
[TBL] [Abstract][Full Text] [Related]
23. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
24. Expression and characterization of erythropoietin receptors on normal human bone marrow cells.
Hoshino S; Teramura M; Takahashi M; Motoji T; Oshimi K; Ueda M; Mizoguchi H
Int J Cell Cloning; 1989 May; 7(3):156-67. PubMed ID: 2543713
[TBL] [Abstract][Full Text] [Related]
25. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1.
Kitamura T; Tojo A; Kuwaki T; Chiba S; Miyazono K; Urabe A; Takaku F
Blood; 1989 Feb; 73(2):375-80. PubMed ID: 2537111
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin binding and induced differentiation of Rauscher erythroleukemia cell line red 5-1.5.
Weiss TL; Barker ME; Selleck SE; Wintroub BU
J Biol Chem; 1989 Jan; 264(3):1804-10. PubMed ID: 2463988
[TBL] [Abstract][Full Text] [Related]
27. Specific binding of 125I-rErythropoietin to Friend polycythemia virus-transformed erythroleukemia cells purified by centrifugal elutriation.
Correa PN; Bard V; Axelrad AA
Int J Cell Cloning; 1990 Jan; 8(1):39-53. PubMed ID: 2152936
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
29. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells.
Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673
[TBL] [Abstract][Full Text] [Related]
30. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A
Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908
[TBL] [Abstract][Full Text] [Related]
31. Apparent Epo-independence of erythroid cells infected with the polycythemia-inducing strain of Friend spleen focus-forming virus is not due to Epo production or change in number or affinity of Epo receptors.
Ruscetti SK; Ruscetti FW
Leukemia; 1989 Oct; 3(10):703-7. PubMed ID: 2550708
[TBL] [Abstract][Full Text] [Related]
32. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
33. Characterization of erythropoietin receptor on erythropoietin-unresponsive mouse erythroleukemia cells.
Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
Biochim Biophys Acta; 1988 Aug; 943(2):326-30. PubMed ID: 2840960
[TBL] [Abstract][Full Text] [Related]
34. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor.
Leveque E; Nagel MD; Haye B
Hematol Oncol; 1996 Sep; 14(3):137-46. PubMed ID: 9119358
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the structure of the erythropoietin receptor by ligand blotting.
Atkins HL; Broudy VC; Papayannopoulou T
Blood; 1991 Jun; 77(12):2577-82. PubMed ID: 1646043
[TBL] [Abstract][Full Text] [Related]
36. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C
Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364
[TBL] [Abstract][Full Text] [Related]
37. Subunit structure of the erythropoietin receptor.
McCaffery PJ; Fraser JK; Lin FK; Berridge MV
J Biol Chem; 1989 Jun; 264(18):10507-12. PubMed ID: 2543671
[TBL] [Abstract][Full Text] [Related]
38. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
Hirata J; Sato H; Takahira H; Shiokawa S; Endo T; Nishimura J; Katsuno M; Masuda S; Sasaki R; Fukumaki Y
Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
[TBL] [Abstract][Full Text] [Related]
39. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
40. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
